Bioavailability Enhancement

Quality by Design in Solid-Dosage Manufacturing

Date: 
September 2, 2015
Short Description: 
According to Sven Stegemann, Director of Pharmaceutical Business Development at Capsugel, the introduction of QbD has triggered a paradigm shift in drug development and manufacturing, and provided a new toolbox of quality principles with several opportunities for the pharmaceutical industry.

In the September 2015 issue of PharmTech, Sven Stegemann is featured in an article on QbD in solid-dosage manufacturing. Read the full article here.

The quality-by-design (QbD) initiative, which focuses on building quality into a product from early on in the development process, has created a shift in the way pharmaceutical companies develop and produce drug products. With a focus on patient safety, QbD helps drug manufacturers incorporate a risk-based approach to development and production.

Continue Reading

Pages

Subscribe to RSS - Bioavailability Enhancement